CHRISTOPHER RUTHRUFF: Open Payments
NPI 1831144179 · IONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 45 payments from 17 companies in 2025. Trend: 2023 $754 · 2024 $1,013 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $217 |
| ABBVIE INC. | 7 | $140 |
| Otsuka America Pharmaceutical, Inc. | 6 | $135 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Dexcom, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Exact Sciences Corporation | 2 | $30 |
Products named: REXULTI, VRAYLAR, Ozempic, Rybelsus, Wegovy, JARDIANCE, Dexcom G6 Transmitter, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
